BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31637871)

  • 1. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling.
    Hu X; Wang R; Ren Z; Liu X; Gu J; Cui G; Li Q
    Cancer Med; 2019 Dec; 8(17):7359-7371. PubMed ID: 31637871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
    Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
    Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
    Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
    Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
    Tan A; Li Q; Chen L
    Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation.
    Gong T; Ning X; Deng Z; Liu M; Zhou B; Chen X; Huang S; Xu Y; Chen Z; Luo R
    J Cell Biochem; 2019 Oct; 120(10):16934-16945. PubMed ID: 31104336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway.
    Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R
    Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway.
    Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
    Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
    Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
    Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
    Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.